Publications

Showing 500 publications

Cost utility of behavioural activation delivered by the non-specialist

  • Paper

View Cost utility of behavioural activation delivered by the non-specialist publication

Cost-Effectiveness of Collaborative Care for Depression in UK Primary Care: Economic Evaluation of a Randomised Controlled Trial (CADET)

  • Paper

View Cost-Effectiveness of Collaborative Care for Depression in UK Primary Care: Economic Evaluation of a Randomised Controlled Trial (CADET) publication

Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer

  • Paper

View Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer publication

Cost-effectiveness of Identification and Referral to Improve Safety (IRIS), a domestic violence training and support programme for primary care: a modelling study based on a randomised controlled trial

  • Paper

View Cost-effectiveness of Identification and Referral to Improve Safety (IRIS), a domestic violence training and support programme for primary care: a modelling study based on a randomised controlled trial publication

Cost-effectiveness of a programme to detect and provide better care for female victims of intimate partner violence

  • Paper

View Cost-effectiveness of a programme to detect and provide better care for female victims of intimate partner violence publication

Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study

  • Paper

View Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study publication

Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukaemia

  • Paper

View Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukaemia publication

Cost-effectiveness of bevacizumab for diabetic macular oedema

  • Paper

View Cost-effectiveness of bevacizumab for diabetic macular oedema publication

Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia

  • Paper

View Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia publication

Cost-effectiveness of oromucosal cannabis-based medicine (Sativex) for spasticity in multiple sclerosis

  • Paper

View Cost-effectiveness of oromucosal cannabis-based medicine (Sativex) for spasticity in multiple sclerosis publication

Previous page

Next page